- Home
- PRPO vs CING Comparison
PRPO vs CING Comparison
Compare PRPO & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- CING
- Stock Information
- Founded
- PRPO N/A
- CING 2012
- Country
- PRPO United States
- CING United States
- Employees
- PRPO N/A
- CING N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- CING Health Care
- Exchange
- PRPO Nasdaq
- CING Nasdaq
- Market Cap
- PRPO 22.0M
- CING 22.0M
- IPO Year
- PRPO N/A
- CING 2021
- Fundamental
- Price
- PRPO $17.59
- CING $3.72
- Analyst Decision
- PRPO
- CING Strong Buy
- Analyst Count
- PRPO 0
- CING 4
- Target Price
- PRPO N/A
- CING $31.00
- AVG Volume (30 Days)
- PRPO 16.8K
- CING 132.0K
- Earning Date
- PRPO 11-05-2025
- CING 11-06-2025
- Dividend Yield
- PRPO N/A
- CING N/A
- EPS Growth
- PRPO N/A
- CING N/A
- EPS
- PRPO N/A
- CING N/A
- Revenue
- PRPO $21,242,000.00
- CING N/A
- Revenue This Year
- PRPO N/A
- CING N/A
- Revenue Next Year
- PRPO N/A
- CING N/A
- P/E Ratio
- PRPO N/A
- CING N/A
- Revenue Growth
- PRPO 27.05
- CING N/A
- 52 Week Low
- PRPO $3.90
- CING $3.02
- 52 Week High
- PRPO $22.38
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- PRPO 54.11
- CING 40.66
- Support Level
- PRPO $17.00
- CING $3.62
- Resistance Level
- PRPO $22.38
- CING $4.00
- Average True Range (ATR)
- PRPO 1.35
- CING 0.20
- MACD
- PRPO -0.13
- CING 0.01
- Stochastic Oscillator
- PRPO 40.83
- CING 22.20
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.